Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patty M Jansen

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Blood|October 16, 2007
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 casesRein Willemze, Patty M Jansen, Lorenzo Cerroni, et al.
Blood|March 9, 2018
High prevalence of <i>MYD88</i> and <i>CD79B</i> mutations in intravascular large B-cell lymphomaAnne M R Schrader, Patty M Jansen, Rein Willemze, et al.
Cancers|April 23, 2022
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical ApproachFleur A de Groot, Ruben A L de Groen, Anke van den Berg, et al.
Blood Advances|October 3, 2024
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosisPaul G Kemps, F J Sherida H Woei-A-Jin, Koen D Quint, et al.
Blood Advances|September 3, 2021
Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotypeRuben A L de Groen, Ronald van Eijk, Stefan Böhringer, et al.
Blood Cancer Journal|April 29, 2025
Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironmentRuben A L de Groen, Fleur A de Groot, Stefan Böhringer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2024
Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapiesFleur A de Groot, Tim J A Dekker, Jeanette K Doorduijn, et al.
Leukemia|June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid NeoplasmsRita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Leukemia|July 19, 2023
Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Blood|October 16, 2007
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 casesRein Willemze, Patty M Jansen, Lorenzo Cerroni, et al.
Blood|March 9, 2018
High prevalence of <i>MYD88</i> and <i>CD79B</i> mutations in intravascular large B-cell lymphomaAnne M R Schrader, Patty M Jansen, Rein Willemze, et al.
Cancers|April 23, 2022
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical ApproachFleur A de Groot, Ruben A L de Groen, Anke van den Berg, et al.
Blood Advances|October 3, 2024
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosisPaul G Kemps, F J Sherida H Woei-A-Jin, Koen D Quint, et al.
Blood Advances|September 3, 2021
Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotypeRuben A L de Groen, Ronald van Eijk, Stefan Böhringer, et al.
Blood Cancer Journal|April 29, 2025
Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironmentRuben A L de Groen, Fleur A de Groot, Stefan Böhringer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2024
Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapiesFleur A de Groot, Tim J A Dekker, Jeanette K Doorduijn, et al.
Leukemia|June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid NeoplasmsRita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Leukemia|July 19, 2023
Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Pageof 6